Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying results 1 - 12 of 30
General Hepatology
EASL Policy Dialogues S3 E2: World Liver Day – Join us in celebrating liver health on a global scale

EASL Policy Dialogues S3 E2: World Liver Day – Join us in celebrating liver health on a global scale

EASL Policy Dialogues
View
Metabolism, Alcohol & Toxicity
On-demand Webinar: Steatotic liver disease – the missing piece in the NCD puzzle

On-demand Webinar: Steatotic liver disease – the missing piece in the NCD puzzle

On-demand Webinars
View
Liver Tumours
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
Metabolism, Alcohol & Toxicity
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues
View
Viral Hepatitis
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
General Hepatology
EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

Podcasts
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

Podcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline

Non-alcoholic fatty liver disease: A patient guideline

PDF
View
Metabolism, Alcohol & Toxicity
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Liver Tumours
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Displaying results 1 - 12 of 30